Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Kalpataru inks Rs 1,250 crore cluster redevelopment in Mumbai’s Kandivali
Realty developer Kalpataru has secured a significant cluster redevelopment project in Ashok Nagar, Kandivali. This project, spanning 2.8 acres, involves five housing societies and has a gross development value of approximately Rs 1,250 crore. The development will feature residential spaces and high-street retail.
Kalpataru expects Rs 1,250 crore revenue from new cluster redevelopment project in Mumbai
Realty firm Kalpataru Ltd anticipates a revenue of Rs 1,250 crore from a significant cluster redevelopment project in Ashok Nagar, Kandivali East, Mumbai. This project involves five adjacent societies and spans 2.8 acres. The company views redevelopment as a way to revitalise communities. Kalpataru Ltd is a major real estate developer with numerous completed and ongoing projects across India.
Kalpataru bags Mumbai redevelopment project with ₹1,250 crore revenue potential
The development is planned as a residential project with high-street retail, strategically located in a well-developed micro-market with connectivity to major road networks and metro lines.
Kalpataru Projects International gains after Q4 PAT climbs 93% YoY to Rs 434 crore
Kalpataru Projects International rallied 3.12% to Rs 1,264.70 after the company reported a 92.63% year-on-year (YoY) surge in consolidated net profit to Rs 434.21 crore in Q4 FY26, compared with Rs 225.41 crore in the corresponding quarter last year.
Kalpataru Projects Q4 net profit jumps 2X on strong execution; declares ₹11 dividend
Shares of Kalpataru Projects International Ltd ended at ₹1,227.50, down by ₹0.45, or 0.037%, on the BSE.
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks Today - Equitymaster
Cohance Lifesciences Q4 FY26 Results | Kalpataru Q4 FY26 Results | Top Buzzing Stocks TodayEquitymaster
Kalpataru consolidated net profit rises 1326.83% in the March 2026 quarter
Sales rise 183.76% to Rs 1693.73 crore
Stocks to Watch for May 13: Dixon, Neuland, Torrent Power, Tata Power, Bharti Airtel and more
Tata Power, Torrent Power and Dr. Reddy's report weaker Q4, Berger Paints, Neuland Laboratories, MTAR Technologies and Kalpataru Projects post strong gains, Vodafone Idea plans fundraise. Here are few stocks to keep an eye on ahead of Wednesday's trading session.
Kalpataru FY26 pre-sales up 17% to Rs 5,280 cr; Q4 net profit at Rs 194 cr
Kalpataru delivered its strongest operational performance with record pre-sales, collections, and profit growth driven by strong demand across Mumbai projects. Improved sale realisations, robust project completions, and debt reduction strengthened the developer’s financial position despite accounting-related revenue recognition timing differences.
Kalpataru posts strong Q4; net profit jumps 14x on 184% revenue growth, EBITDA turnaround
EBITDA stood at ₹217.4 crore in Q4FY26, compared with an EBITDA loss of ₹19.7 crore in the same period last year. Shares of Kalpataru Limited ended at ₹382.20, down by ₹0.95, or 0.25%, on the BSE.
Q4 Results LIVE Updates: Dr. Reddy's, Dixon report results today; Indian Hotels, Anant Raj react
Q4 Results LIVE Updates: Its an earnings-heavy day on the Dalal Street today. Nifty 50 stock Dr Reddy's Laboratories is scheduled to report its numbers today. Dixon Tech, Berger Paints, Nazara Tech, INOX India, Cohance Lifesciences, Gopal Snacks, Kalpataru, KPR Mill, Max Financial Services, MobiKwik, MTAR Tech, Novartis, Pfizer, Religare, Keystone Developers, Sagility, Tata Power, Torrent Power, Texmaco Rail, V-Guard Industries, are among the other important results to track today. Watch this space for all the LIVE earnings updates.